INSIDER
Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Read full article: Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugsMillions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 billion proposal from the Biden administration is blessed by President-elect Donald Trump.
Congress targets Chinese influence in health tech. It could come with tradeoffs
Read full article: Congress targets Chinese influence in health tech. It could come with tradeoffsA San Jose-based biotechnology company that helps doctors detect genetic causes for cancer is among those that could be cut out of the U.S. market over ties to China.
AP Decision Notes: What to expect in Ohio's presidential and state primaries
Read full article: AP Decision Notes: What to expect in Ohio's presidential and state primariesThe most high-profile election in Ohio’s primary on Tuesday will be the Republican contest to take on the state’s Democratic U.S. senator.
New weight loss drugs are out of reach for millions of older Americans because Medicare won't pay
Read full article: New weight loss drugs are out of reach for millions of older Americans because Medicare won't payObesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds.
Anthony Fauci will testify before Congress on COVID origins and the US pandemic response
Read full article: Anthony Fauci will testify before Congress on COVID origins and the US pandemic responseFormer chief White House medical adviser Anthony Fauci is expected to testify before Congress early next year as part of Republicans’ yearslong investigation into the origins of COVID-19 and the U.S. response to the disease.
The GOP congressman who leads the House’s probe of COVID-19′s origins says he won’t seek reelection
Read full article: The GOP congressman who leads the House’s probe of COVID-19′s origins says he won’t seek reelectionThe Republican congressman who leads the House GOP's investigation of the origins of COVID-19 says he won't seek reelection next year.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/D7BCT62ZVFEDNPSMSSPHGMK46A.jpg)
GOP seeks to convince vaccine skeptics within its own ranks
Read full article: GOP seeks to convince vaccine skeptics within its own ranksWith vaccination rates lagging in red states, Republican leaders have begun stepping up efforts to persuade their supporters to get the shot, at times combating misinformation spread by some of their own.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/MHAFOM4NYBEHRPVBHZYZMOC4EQ.jpg)
Trump, Lee, Tillis: Congress reconsiders testing its own
Read full article: Trump, Lee, Tillis: Congress reconsiders testing its ownMike Lee, R-Utah, and Thom Tillis, R-N.C., became the latest members of Congress to test positive for the virus that has killed more than 205,000 Americans. All three attended the White House Rose Garden introduction Saturday of Trump's nominee for the Supreme Court, Amy Coney Barrett. Nationally and on Capitol Hill, there are no comprehensive plans requiring testing or wearing masks. House members can vote by proxy through their colleagues, to cut down on the number of people milling around. Lee, Tillis and other Republican members of the panel were among those who attended the Rose Garden event on Saturday.